SciePro / stock.adobe.com
Patients participating in a pioneering lung screening program in Leeds will now have the opportunity to be screened for kidney cancer with additional funding from Yorkshire Cancer Research.
This study, led by Professor Grant Stewart, will examine whether additional testing for kidney cancer can be effectively introduced into mobile lung screening programs. The study follows that of Professor Stewart 2020 Nature Reviews Urology paper examination of the feasibility of screening for kidney cancer.
About six in ten people with kidney cancer don’t have symptoms and are often only diagnosed by testing for another condition or reason. This means that more than a third of patients are diagnosed at a late stage when the cancer is more difficult to treat. Only six in ten patients with kidney cancer live for 5 years after diagnosis.
Grant Stewart, professor of surgical oncology at the University of Cambridge and head of the study, said: “Kidney cancer is currently a silent and deadly disease. Often times, it is not diagnosed until the disease has passed the stage at which we can easily cure it. Since kidney cancer is largely curable if identified at an early stage in the absence of symptoms, the scientific community has been interested for many years in developing a potential screening program for this “silent” cancer. “
“To determine if screening is possible, we will rely on the Leeds Lung Health Check and offer additional CT scans for kidney cancer to those participating in this important clinical trial. The additional scan will only take 10 seconds. “
“This will be the first study in the world to address the uncertainties and test the clinical rationale and logistics needed to see if we can develop a comprehensive clinical trial for kidney cancer screening as part of a health monitoring program.” pulmonary. By the end of the feasibility study, we will understand whether we can and should undertake a full kidney cancer screening clinical trial, because we will know if people are likely to do this additional analysis.
Andrew Macnamara’s story demonstrates the importance of screening for kidney cancer while it is treatable. He said, “They told me that something appeared on the CT scan I had for my lungs. They had grabbed the top of my kidney on the lung scan and noticed it was enlarged, they said I needed a closer look to find out why. Andrew made a full recovery after the nephrectomy and got the go-ahead at the end of 2020.
“I think adding kidney scans to the Leeds Lung Health Check is a good thing. I was lucky the doctors noticed something abnormal on my lung scan as they grabbed the top of the kidney but then had to have a separate scan in the hospital to fully check my kidneys . If they can scan all of the kidneys with the lungs at the same time, that will be fantastic.
This trial is funded by Yorkshire Cancer Research, delivered in partnership with Leeds Teaching Hospitals NHS Trust, University of Leeds and Leeds City Council.